Gene test shows who could benefit from statins to reduce colon cancer risk
Friday, April 23, 2010 - 00:30
in Health & Medicine
A genetic test can help determine in which patients cholesterol-lowering statin drugs might have the most benefit in also reducing the risk of colorectal cancer, a new study finds.